Timberlyne Therapeutics

San Diego, CA · Founded 2024 · Privately Held (backing)

Operator of a biopharmaceutical company intended to develop and commercialize therapies for autoimmune diseases. Timberlyne Therapeutics is based in San Diego, CA and was founded in 2024. Its last reported valuation was $324 million in Jan 2025. It has raised $180 million.

Last reported valuation

$324.2M

Oct 2026

Priced at

—

Total raised

$180.0M

Last round

—

How much has Timberlyne Therapeutics raised?

$180.0Macross 0 recorded rounds

Free account

More of Timberlyne Therapeutics with a free account

·Watch Timberlyne Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Timberlyne Therapeutics investors

7 investors are on record for Timberlyne Therapeutics, including Venrock, Boyu Capital, Bain Capital Life Sciences and Braidwell.

For fundraisers

Raising for a company like Timberlyne Therapeutics?

7 investors have backed Timberlyne Therapeutics.

See all 7 investors →

Frequently asked about Timberlyne Therapeutics

How much has Timberlyne Therapeutics raised?: Timberlyne Therapeutics has raised $180.0M in total across 0 recorded funding rounds.